Gain Control of Bleeding
In the Treatment of Congenital Fibrinogen Deficiency (CFD)

Fibryga is a human fibrinogen indicated for the treatment of acute bleeding episodes in adults and children with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia.1

Fibryga is not indicated for dysfibrinogenemia.1

For more information on our New Indication, please .

References:
  1. Fibryga full Prescribing Information. Paramus, NJ: Octapharma; rev 2024.
  2. Lissitchkov T, Madan B, Djambas Khayat C, et al. Efficacy and safety of a new human fibrinogen concentrate in patients with congenital fibrinogen deficiency: an interim analysis of a Phase III trial. Transfusion. 2018;58:413-422.